Trials / Sponsors / Design Therapeutics, Inc.
Design Therapeutics, Inc.
Industry · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy Fuchs Endothelial Corneal Dystrophy, Fuchs | Phase 2 | 2025-07-30 |
| Recruiting | A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia Friedreich Ataxia | Phase 1 / Phase 2 | 2025-06-01 |
| Not Yet Recruiting | A Single Ascending Dose Study of DT-216P2 in Normal Healthy Participants Friedreich Ataxia | Phase 1 | 2025-02-01 |
| Completed | Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich Ataxia Friedreich Ataxia | Phase 1 | 2022-09-27 |
| Completed | Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia Friedreich Ataxia | Phase 1 | 2022-03-11 |